Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Immunol Lett. 2016 Nov 22;181:58–62. doi: 10.1016/j.imlet.2016.11.011

Table 2.

GWAS datasets.

Dataset Disease Source (accession
no.)
Ref. Cases
(F/M ratio)
Controls
(F/M ratio)
ALS Finland Amyotrophic Lateral Sclerosis (ALS) dbGaP (phs000344) [17] 400
(1.02)
490
(3.76)
ALS Irish Amyotrophic Lateral Sclerosis (ALS) dbGaP (phs000127) [18] 221
(0.86)
210
(0.87)
Celiac disease CIDR Celiac disease dbGaP (phs000274) [19] 1576
(2.52)
504
(1.24)
MS Case Control Multiple Sclerosis (MS) dbGaP (phs000171) [20] 943
(2.02)
851
(1.93)
MS WT2 Multiple Sclerosis (MS) WT2 [21] 2666
(2.82)
1389
(0.98)
Vitiligo GWAS1 Vitiligo dbgaP (phs000224) [22] 1391
(2.38)
4521*
(1.28)
Vitiligo GWAS2 Vitiligo - [23] 415
(1.88)
2552*
(1.62)
CD NIDDK Chron's disease (CD) dbGaP (phs000130) [24] 791
(1.09)
922
(1.02)
CDWT1 Crohn’s disease (CD) WT1 [25] 1592
(1.62)
1701
(0.84)
Psoriasis CASP Psoriasis dbGaP (phs000019) [26] 1209
(1.06)
1271
(1.17)
T2D GENEVA Type-2 Diabetes (T2D) dbGaP (phs000091) [27] 2515
(1.39)
2850
(1.40)
T2D WT1 Type-2 Diabetes (T2D) WT1 [25] 1811
(0.72)
1668
(1.35)
T1D WT1 Type-1 Diabetes (T1D) WT1 [25] 1867
(0.96)
1714
(0.82)
RA WT1 Rheumatoid Arthritis (RA) WT1 [25] 1772
(3.00)
1709
(0.86)
AS WT2 Ankylosing Spondylitis (AS) WT2 [28] 1472
(0.51)
1260
(0.89)
UC WT2 Ulcerative Colitis (UC) WT2 [29] 2341
(1.04)
1699
(1.01)
*

Controls were obtained from dbGaP: phs000206 [30,31], phs000168 [32], phs000138 [33], phs000125 [34], phs000092 [3436].

Abbreviations: WT1 (2), Wellcome Trust Case Control Consortium 1 (2).